The impact of statin therapy on plasma asymmetric dimethylarginine (ADMA) levels has not
been conclusively studied. Therefore the aim of the meta-analysis was to assess the effect of …

Considering the high prevalence of cardiovascular diseases (CVDs), the primary cause of
death during the last several decades, it is necessary to develop proper strategies for the …

Background Atherosclerosis is a major cardiovascular disease that causes ischemia of the
heart, brain, or extremities, and can lead to infarction. The hypolipidemic agent atorvastatin …

The metabolic syndrome (MetS) is a cluster of risk factors including insulin resistance,
dyslipidemia and hypertension which are also relevant for the development of chronic …

The key lipid-lowering target is to achieve guideline-recommended low-density lipoprotein
cholesterol (LDL-C) levels, usually by using statins. The new treatment strategies for lipid …

The year 2013 proved to be very exciting as far as landmark trials and new guidelines in the
field of lipid disorders, blood pressure and kidney diseases. Among these are the …

The prevalence of atrial fibrillation (AF) increases with age. As the population ages, the
burden of AF increases. AF is associated with an increased incidence of mortality, stroke …

The role of statins in the treatment and prevention of cardiovascular diseases, such as
coronary artery disease, acute coronary syndromes, diabetes or stroke is well established …

Background: Atherosclerosis and its complications represent the leading cause of morbidity
and mortality. Heat shock protein 70 (HSP70) protects cellular elements from injury by …

Intimal hyperplasia (IH) is the major cause of grafted vessel occlusion and occurs frequently
after bypass intervention. No pharmaceutical formulation is currently available to prevent this …